Endocrine Adverse Events Caused by Different Types and Different Doses of Immune Checkpoint Inhibitors in the Treatment of Solid Tumors: A Meta‐Analysis and Systematic Review-Reference-Cited by-同舟云学术

Endocrine Adverse Events Caused by Different Types and Different Doses of Immune Checkpoint Inhibitors in the Treatment of Solid Tumors: A Meta‐Analysis and Systematic Review

Published:2021-01-12 Issue:3 Volume:61 Page:282-297
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Yang Yaxian¹,Liu Jingfang¹²,Yang Kaili¹,Ma Yanqi¹,Fu Songbo¹²,Tang Xulei¹²,Wang Yan²,Zhou Liyuan²

Affiliation:

1. The First Clinical Medical College Lanzhou University Lanzhou Gansu China

2. Department of Endocrinology the First Hospital of Lanzhou University Lanzhou Gansu China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1804

Reference56 articles.

1. Immune checkpoint blockade therapy

2. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways

3. CTLA-4 and PD-1 Pathways

4. Management of toxicities of immune checkpoint inhibitors

5. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pituitary Complications of Checkpoint Inhibitor Use;Endocrinology;2024-07-13

2. Immune Checkpoint Inhibition;Side Effects of Cancer Therapy;2024

3. Endocrine toxicity of immune checkpoint inhibitors: a network meta-analysis of the current evidence;Acta Materia Medica;2024

4. Risk and Incidence of Endocrine Immune-Related Adverse Effects Under Checkpoint Inhibitor Mono- or Combination Therapy in Solid Tumors: A Meta-Analysis of Randomized Controlled Trials;The Journal of Clinical Endocrinology & Metabolism;2023-11-15

5. Immune Checkpoint Inhibition;Side Effects of Cancer Therapy;2023-10-31